Company intelligence / Profile preview

Nexien BioPharma

Colorado Springs, Colorado, United States

Ownership: Private
Development stage: Other

Overview

Nexien BioPharma is a US-based pharmaceutical company focused on the development of cannabinoid-based therapeutics for the treatment of neurological disorders and other medical conditions. The company's primary research efforts target orphan diseases, specifically focusing on Cervical Dystonia (Spasmodic Torticollis) and Epilepsy. Nexien utilizes a formulation-driven approach to develop synthetic cannabinoid products that meet FDA regulatory standards for safety and efficacy. By leveraging the therapeutic potential of the endocannabinoid system, the company aims to provide standardized, pharmaceutical-grade alternatives to existing treatments. The company operates as a public entity, trading under the symbol NXEN.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Nexien BioPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexien BioPharma.

Explore the full profile